COMPASS THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
COMPASS THERAPEUTICS, INC. (CMPX) reported Increase Decrease In Operating Lease Liability of -$196.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$158.00K.
- COMPASS THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$38.00K.
- COMPASS THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$38.00K.
- COMPASS THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$37.00K, a 840.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$369.00K.
- COMPASS THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$1.22M.
- COMPASS THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$1.20M.
- COMPASS THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$1.10M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$196.00K 10-Q · filed 2026-08-06 | -$234.00K derived: sum of 3 quarters · filed 2026-08-06 | -$271.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$38.00K 10-Q · filed 2026-05-05 | -$76.00K derived: sum of 2 quarters · filed 2026-05-05 | -$113.00K derived: sum of 3 quarters · filed 2026-05-05 | -$154.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$75.00K derived: sum of 2 quarters · filed 2026-03-05 | -$116.00K derived: sum of 3 quarters · filed 2026-08-06 | -$369.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$78.00K derived: sum of 2 quarters · filed 2026-08-06 | -$331.00K 10-Q · filed 2025-11-05 | -$908.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$294.00K 10-Q · filed 2026-08-06 | -$871.00K derived: sum of 3 quarters · filed 2026-08-06 | -$866.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$253.00K 10-Q · filed 2026-05-05 | -$830.00K derived: sum of 2 quarters · filed 2026-05-05 | -$825.00K derived: sum of 3 quarters · filed 2026-05-05 | -$1.15M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$577.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$572.00K derived: sum of 2 quarters · filed 2026-03-05 | -$897.00K derived: sum of 3 quarters · filed 2026-03-05 | -$1.22M 10-K · filed 2026-03-05 |
| 2024-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$320.00K derived: sum of 2 quarters · filed 2025-11-05 | -$640.00K 10-Q · filed 2025-11-05 | -$950.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$325.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$645.00K 10-Q · filed 2025-08-11 | -$955.00K derived: sum of 3 quarters · filed 2025-08-11 | -$1.26M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$320.00K 10-Q · filed 2025-05-08 | -$630.00K derived: sum of 2 quarters · filed 2025-05-08 | -$931.00K derived: sum of 3 quarters · filed 2025-05-08 | -$1.23M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$611.00K derived: sum of 2 quarters · filed 2025-02-27 | -$909.00K derived: sum of 3 quarters · filed 2025-02-27 | -$1.20M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$301.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$599.00K derived: sum of 2 quarters · filed 2024-11-12 | -$892.00K 10-Q · filed 2024-11-12 | -$1.18M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$591.00K 10-Q · filed 2024-08-12 | -$875.00K derived: sum of 3 quarters · filed 2024-08-12 | -$1.15M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$293.00K 10-Q · filed 2024-05-13 | -$577.00K derived: sum of 2 quarters · filed 2024-05-13 | -$853.00K derived: sum of 3 quarters · filed 2024-05-13 | -$1.13M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$560.00K derived: sum of 2 quarters · filed 2024-03-21 | -$832.00K derived: sum of 3 quarters · filed 2024-03-21 | -$1.10M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$548.00K derived: sum of 2 quarters · filed 2023-11-09 | -$818.00K 10-Q · filed 2023-11-09 | -$1.18M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$542.00K 10-Q · filed 2023-08-03 | -$906.00K derived: sum of 3 quarters · filed 2023-08-03 | -$1.16M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$270.00K 10-Q · filed 2023-05-04 | -$634.00K derived: sum of 2 quarters · filed 2023-05-04 | -$886.00K derived: sum of 3 quarters · filed 2023-05-04 | -$1.14M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$616.00K derived: sum of 2 quarters · filed 2023-03-15 | -$865.00K derived: sum of 3 quarters · filed 2023-03-15 | -$1.11M 10-K · filed 2023-03-15 |
| 2021-09-30 | -$252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$501.00K derived: sum of 2 quarters · filed 2022-11-09 | -$747.00K 10-Q · filed 2022-11-09 | |
| 2021-06-20 | -$249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | -$495.00K 10-Q · filed 2022-08-01 | ||
| 2021-03-31 | -$246.00K 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |